This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Improving fatigue and loss of appetite caused by chemotherapy in cancer patients.
Medical statistics show that almost all cancer patients undergoing chemotherapy experience side effects, including fatigue, loss of appetite, decreased immunity, vomiting, and diarrhea, causing significant suffering for patients. In recent years, the U.S. FDA has regarded improving the side effects of cancer treatment as an important indicator.
Department of Health Manufacturing Approval No. 015926. Please read the instructions and precautions carefully before use. If you have any questions, please consult a doctor or pharmacist.
After 14 years of R&D and an investment of over NT$1 billion, Microbio has developed the oral cancer drug ‘MS-20’ in accordance with international new drug development standards. In December 2011, it obtained the new drug approval for oral cancer adjuvant therapy in Taiwan. MS-20 effectively improves fatigue and loss of appetite caused by chemotherapy in cancer patients, enhancing their ability to maintain family and social activities. Clinical results are significant, with patients taking MS-20 showing much better physical strength, mental state, appetite, and quality of life compared to those who do not take it.
Due to its good safety profile, the Taiwan Department of Health has approved it for sale as an ‘over-the-counter’ drug. It can be sold in hospitals, clinics, and pharmacies with doctors and pharmacists on site, without being limited to hospital prescription drugs. This is a great blessing for cancer patients.
❶ Improve symptoms of fatigue and loss of appetite caused by chemotherapy in patients.
❷ Prevent malnutrition and decreased immunity caused by fatigue and loss of appetite in chemotherapy patients, helping them complete the full course of treatment and improve their quality of life.
❸ Convenient oral use with good safety and no obvious side effects.
PRODUCT INFORMATION
【Indications】 Improve fatigue and loss of appetite in cancer patients treated with chemotherapy.
【Packaging】4 mL in a glass bottle, 14 bottle per box
【Storage Conditions】Store away from light at room temperature.
【Ingredients】 MS-20 oral solution, made from various lactic acid bacteria and yeast. Each mL contains the fermented extract of 2.7 grams of soybean.
【Usage & Dosage】4 mL each time, twice a day. Dilute with 100 mL of warm water and take on an empty stomach.
【Precautions】
- Follow the instructions of your doctor, pharmacist, or chemist. If you feel unwell, visit a qualified medical institution or contact your doctor.
- This product is for oral use. Drink plenty of water after use.
- Solid crystals forming at the bottle mouth or bottom are a natural phenomenon. Remove and dissolve in warm water before drinking.
【Adverse Reactions】
- This product is generally safe. In clinical trials, no significant adverse reactions were observed when used with chemotherapy compared to chemotherapy alone.
- This product may cause temporary mild constipation or diarrhea, which will improve with continuous use.
- If you are sensitive to soybean products, consult your doctor, pharmacist, or chemist before use.
Taipei City Department of Health Advertisement Approval No. 107090180